Compensation award — excluded from discretionary-purchase analysis.
Loading…
Reporting person on SEC Form 4
Brian Foard
Brian Foard is EVP, Specialty, Pharma, & ID at Merck. OQRO lists 3 transactions filed with the SEC under this name, the latest on May 7, 2026, each linked to the official Form 4.
EVP, Specialty, Pharma, & ID
Disclosures on record
3
Companies involved
1
Disclosure history
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.